drugset / Trial / NCT02111304

Efficacy of iOWH032 in Dehydrating Cholera

NCT02111304

RandomizedParallel-groupDouble-blindTreatment

Summary

The primary hypothesis is that administration of iOWH032 to adult and pediatric males and females with acute cholera due to V. cholerae O1 reduces stool output in the first 24 hours significantly more than does the current standard of care.

Timeline

Start
2014-06
Primary completion
2016-01
Completion
2016-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator iOWH032 Small molecule 500 mg

Indications